Drug-resistant childhood-onset epilepsies and disease models for novel drug target discovery (DIAMOND)
Description of the granted funding
The World Health Organisation (WHO) classifies epilepsy as a major public health problem. One-third of patients have severe epilepsies, which lead to decreased quality of life and may adversely affect cognitive development, especially in children. There is a significant need to develop treatment options for severe epilepsies. We will combine clinical data and patient-derived disease models to identify previously unknown causes and mechanisms of severe epilepsy. This project will be conducted by the Paediatric Neurology Group from the Oulu University Hospital and University of Oulu and the Epilepsia Helsinki Team from the Helsinki University Hospital (HUS) in collaboration with the University of Helsinki, Finland. We aim to find ways to understand, treat, and prevent severe epilepsy and thus alleviate the high burden of severe epilepsy on individuals and their families and on society.
Show moreStarting year
2025
End year
2029
Granted funding
Funder
Research Council of Finland
Funding instrument
Academy projects
Decision maker
Scientific Council for Biosciences, Health and the Environment
16.06.2025
16.06.2025
Other information
Funding decision number
369453
Research fields
Kliiniset lääketieteet